Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (1) , 53-62
Abstract
Fisetin (3,3',4',7-tetrahydroxyflavone), a natural abundant flavonoid, is produced in different vegetables and fruits. Fisetin has been reported to relate to various positive biological effects, including anti-proliferative, anticancer, anti-oxidative and neuroprotective effects. Dopamine receptors (DRs) belonging to G protein‑coupled receptor family, are known as the target of ~50% of all modern medicinal drugs. DRs consist of various proteins, functioning as transduction of intracellular signals for extracellular stimuli. We found that fisetin performed as DR2 agonist to suppress liver cancer cells proliferation, migration and invasion. Caspase-3 signaling was activated to induce apoptosis for fisetin administration. Furthermore, TGF‑β1 was also inhibited in fisetin-treated liver cancer cells, reducing epithelial-mesenchymal transition (EMT). Additionally, fisetin downregulated VEGFR1, p-ERK1/2, p38 and pJNK, ameliorating liver cancer progression. In vivo, the orthotopically implanted tumors from mice were inhibited by fisetin adminisatration accompanied by prolonged survival rate and higher levels of dopamine. Together, the results indicated a novel therapeutic strategy to suppress liver cancer progression associated with DR2 regulation, indicating that dopamine might be of importance in liver cancer progression.Keywords
This publication has 36 references indexed in Scilit:
- Schizonepeta tenuifolia Ethanol Extract Exerts Anti-Inflammatory Activity Through the Inhibition of TLR4 Signaling in Lipopolysaccharide-Stimulated Macrophage CellsJournal of Medicinal Food, 2014
- Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinomaWorld Journal of Surgical Oncology, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Hepatocellular carcinoma: a review of the surgical approaches to management.2011
- Hepatocellular CarcinomaAnnals of Surgery, 2011
- An overview of evidence-based management of hepatocellular carcinoma: A meta-analysisJournal of Cancer Research and Therapeutics, 2011
- Current management strategy of hepatocellular carcinomaWorld Journal of Gastroenterology, 2009
- Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivoGut, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatinExperimental Eye Research, 2007